Apidra SoloSTAR (insulin glulisine [rDNA origin] injection, from sanofi-aventis), a prefilled disposable pen containing Apidra, is now available. Apidra SoloSTAR makes administration of insulin more ...
BRIDGEWATER, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Apidra(R) SoloSTAR(R ...
PARIS, Feb 26 (Reuters) - Sanofi-Aventis has won U.S. approval to market its Apidra Solostar injection pen which contains insulin to treat diabetes, the world's third-biggest drugmaker said on ...
PARIS, February 14 Sanofi-aventis announcedtoday that the Chicago Athenaeum Museum of Architecture and Design hasawarded a 2007 GOOD DESIGN(TM) Award for the new SoloSTAR(R) disposableinsulin ...
In January 2008, sanofi aventis officially launched a new disposable pen for its LANTUS® and APIDRA® insulin. Named SoloSTAR®, the device was sampled firsthand by doctors who attended the events ...
Sanofi announced today, at the 71st Scientific American Diabetes Association Sessions 2011, the results of three studies showing that people with diabetes using Sanofi insulins Lantus(R) and/or Apidra ...
Sanofi-aventis announced today that a new disposable insulin pen, SoloSTAR® for use with the 24-hour insulin LANTUS® or/and the rapid-acting insulin APIDRA® will be available in South Africa starting ...
French pharmaceutical manufacturer Sanofi recently notified doctors that they will soon face a shortage of an insulin pen product. The shortage is caused by a "technical incident" at a manufacturing ...
The FDA has approved Apidra SoloSTAR (insulin glulisine[rDNA origin] injection, from sanofi-aventis), a prefilled disposable pencontaining Apidra. Apidra SoloSTAR makes administration of insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results